Additionally, our data indicate that specific depletion of FASN gene activity dramatically decreases E2 requirements for optimal transactivation of ERα, further confirming the specific ability of FASN signaling to regulate the degree of sensitivity of breast cancer cells to E2-stimulated ERα-driven transcriptional activity. This evidence concerns the gene ESR1 and breast carcinoma.